InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
OBS | Ann: Removal from the Official List (cob 16/03/2015) | 15/11/15 | 1 | 1.1K | |||
|
|||||||
BDI +OBS | Orbis Natougou vs BDI | 18:16 | 105 | 33K | |||
|
|||||||
OBS | Ann: Suspension from Official Quotation | 14/03/15 | 1 | 915 | |||
|
|||||||
OBS | Ann: SEMAFO - Change in substantial holding | 07/03/15 | 2 | 984 | |||
|
|||||||
OBS | Ann: Half Yearly Report and Accounts | 06/03/15 | 0 | 397 | |||
|
|||||||
OBS | Ann: Ceasing to be a substantial holder | 06/03/15 | 0 | 367 | |||
|
|||||||
OBS | Ann: SEMAFO - Compulsory acquisition of Orbis Gold shares | 03/03/15 | 0 | 664 | |||
|
|||||||
OBS | Ann: SEMAFO - Change in substantial holding | 26/02/15 | 2 | 875 | |||
|
See All Discussions